Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Medical Gas Research
Published in: Medical Gas Research 1/2011

Open Access 01-12-2011 | Case report

Hyperbaric oxygen therapy (1.5 ATA) in treating sports related TBI/CTE: two case reports

Author: Kenneth P Stoller

Published in: Medical Gas Research | Issue 1/2011

Login to get access

Abstract

Despite adequate evidence, including randomized controlled trials; hyperbaric oxygen is not yet recognized as efficacious for treating various forms of brain injury, specifically traumatic brain injury. Political-economic issues have kept this benign therapy from being widely adopted despite the lack of viable alternatives. Two football players with TBI/CTE are herewith shown to benefit from being treated with hyperbaric oxygen as documented by neurocognitive examinations and functional brain imaging, in one case treatment commenced decades after the brain injury. Perhaps the interest in HBOT by those participating in high-risk sports will help expand this orphan therapy into mainstream medicine.
Appendix
Available only for authorised users
Literature
1.
Sluiter ME: The treatment of carbon monoxide poisoning by the administration of oxygen at high atmospheric pressure. Proc R Soc Med. 1963, 1002-8. 56
2.
3.
Stoller KP: Hyperbaric oxygen and carbon monoxide poisoning: a critical review. Neurological Research. 2007, 29: 146-155. 10.1179/016164107X181770.CrossRefPubMed
4.
Duff JH, Shibata HR, Vanschaik L, Usher R, Wigmore RA, MacLean LD: Hyperbaric oxygen: a review of treatment in eighty-three patients. Can Med Assoc J. 1967, 97 (10): 510-5.PubMedCentralPubMed
5.
Workman RD: Oxygen decompression following air dives for use in hyperbaric oxygen therapy. Res Rep 2-64. Rep US Navy Exp Diving Unit. 1964 Dec 15:1-10
6.
Hart GB, Thompson RE: The treatment of cerebral ischemia with hyperbaric oxygen (OHP). Stroke. 1971, 2 (3): 247-50. 10.1161/01.STR.2.3.247.CrossRefPubMed
7.
Neubauer RA, James P: Cerebral oxygenation and the recoverable brain. Neurol Res. 1998, 20 (Suppl 1): S33-6.PubMed
8.
Chang DC, Lee JT, Lo CP, Fan YM, Huang KL, Kang BH, Hsieh HL, Chen SY: Hyperbaric oxygen ameliorates delayed neuropsychiatric syndrome of carbon monoxide poisoning. Undersea Hyperb Med. 2010, 37 (1): 23-33.PubMed
9.
Senol MG, Yildiz S, Ersanli D, Uzun G, Gumus T, Narin Y, Ozkan S, Ayata A: Carbon monoxide-induced cortical visual loss: treatment with hyperbaric oxygen four years later. Med Princ Pract. 2009, 18 (1): 67-9. 10.1159/000163050.CrossRefPubMed
10.
Stoller KP: Hyperbaric oxygen and carbon monoxide poisoning: a critical review. Neurological Research. 2007, 29: 146-155. 10.1179/016164107X181770.CrossRefPubMed
11.
Clifton GL: Hypothermia and hyperbaric oxygen as treatment modalities for severe head injury. New Horiz. 1995, 3 (3): 474-8. ReviewPubMed
12.
Harch PG, Van Meter KW, Gottlieb SF, Staab P: HMPAO SPECT brain imaging and low pressure HBOT in the diagnosis and treatment of chronic traumatic, ischemic, hypoxic and anoxic encephalopathies. Undersea and Hyperbaric Medicine. 1994, 21 (Suppl): 30-
13.
Harch PG, Van Meter KW, Neubauer RA, Gottlieb SF: Use of HMPAO SPECT for assessment of response to HBO in ischemic/hypoxic encephalopathies. Textbook of Hyperbaric Medicine, Appendix. Edited by: Jain KK. 1996, Seattle (WA): Hogrefe &Huber Pubs, 480-491. 2
14.
Harch PG, Neubauer RA: Hyperbaric oxygen therapy in global cerebral ischemia/anoxia and coma. Textbook of Hyperbaric Medicine. Edited by: Jain KK. 1999, Hogrefe & Huber Publishers, Seattle WA, Chapter 18: 319-345. 3
15.
Harch PG, Neubauer RA: Hyperbaric oxygen therapy in global cerebral ischemia/anoxia and coma. Textbook of Hyperbaric Medicine. Edited by: Jain KK. 1999, Hogrefe & Huber Publishers, Seattle WA, Chapter 18: 319-345. 3
16.
Neubauer RA, Gottlieb SF, Pevsner NH: Hyperbaric Oxygen for Treatment of Closed Head Injury. Southern Medical Journal. 1994, 87 (9): 933-936. 10.1097/00007611-199409000-00015.CrossRefPubMed
17.
Barrett KF, Masel BE, Harch PG, Ingram F, Corson KP, Mader JT: Cerebral blood flow changes and cognitive improvement in chronic stable traumatic brain injuries treated with hyperbaric oxygen therapy. Neurol. 1998, A178-A179. Suppl
18.
Harch PG, Andrews SR, Fogarty E, Lucarini J, Aubrey C, Staab PK, Van Meter KW: Hyperbaric Oxygen Therapy Treatment of Chronic Mild-Moderate Blast-Induced Traumatic Brain Injury/Post Concussion Syndrome with Post Traumatic Stress Disorder: Pilot Trial. Presented at 8th World Congress on Brain Injury. 2010, Washington DC
19.
Harch PG, Fogarty EF, Staab PK, Van Meter K: Low pressure hyperbaric oxygen therapy and SPECT brain imaging in the treatment of blast-induced chronic traumatic brain injury (post-concussion syndrome) and post traumatic stress disorder: a case report. Cases J. 2009, 2: 6538-10.4076/1757-1626-2-6538.PubMedCentralCrossRefPubMed
20.
Wright JK, Zant E, Groom K, Schlegel RE, Gilliland K: Case report: Treatment of mild traumatic brain injury with hyperbaric oxygen. Undersea Hyperb Med. 2009, 36 (6): 391-9.PubMed
21.
Lin JW, Tsai JT, Lee LM, Lin CM, Hung CC, Hung KS, Chen WY, Wei L, Ko CP, Su YK, Chiu WT: Effect of hyperbaric oxygen on patients with traumatic brain injury. Acta Neurochir Suppl. 2008, 101: 145-9. 10.1007/978-3-211-78205-7_25.CrossRefPubMed
22.
Rockswold SB, Rockswold GL, Zaun DA, Zhang X, Cerra CE, Bergman TA, Liu J: A prospective, randomized clinical trial to compare the effect of hyperbaric to normobaric hyperoxia on cerebral metabolism, intracranial pressure, and oxygen toxicity in severe traumatic brain injury. J Neurosurg. 2010, 112 (5): 1080-94. 10.3171/2009.7.JNS09363.CrossRefPubMed
23.
Rockswold SB, Rockswold GL, Defillo A: Hyperbaric oxygen in traumatic brain injury. Neurol Res. 2007, 29 (2): 162-72. 10.1179/016164107X181798. ReviewCrossRefPubMed
24.
Rockswold SB, Rockswold GL, Defillo A: Hyperbaric oxygen in traumatic brain injury. Neurol Res. 2007, 29 (2): 162-72. 10.1179/016164107X181798. ReviewCrossRefPubMed
25.
Hardy P, Johnston KM, De Beaumont L, Montgomery DL, Lecomte JM, Soucy JP, Bourbonnais D, Lassonde M: Pilot case study of the therapeutic potential of hyperbaric oxygen therapy on chronic brain injury. J Neurol Sci. 2007, 253 (1-2): 94-105. 10.1016/j.jns.2006.12.005. Epub 2007 Jan 16CrossRefPubMed
26.
Shi XY, Tang ZQ, Sun D, He XJ: Evaluation of hyperbaric oxygen treatment of neuropsychiatric disorders following traumatic brain injury. Chin Med J (Engl). 2006, 119 (23): 1978-82.
27.
Golden Z, Golden CJ, Neubauer RA: Improving neuropsychological function after chronic brain injury with hyperbaric oxygen. Disabil Rehabil. 2006, 28 (22): 1379-86. 10.1080/09638280600638364.CrossRefPubMed
28.
Collins MW, Lovell MR, Mckeag DB: Current Issues in managing sports-related concussion. JAMA. 1999, 282: 2283-2285. 10.1001/jama.282.24.2283.CrossRefPubMed
29.
Collins MW, Grindel SH, Lovell MR, Dede DE, Moser DJ, Phalin BR, Nogle S, Wasik M, Cordry D, Sears SF, Nicolette G, Indelicato P, McKeag D: Relationship between concussion and neuropsychological performance in college football players. JAMA. 1999, 282: 989-991. 10.1001/jama.282.10.989.CrossRef
30.
Iverson GL, Lovell MR, Collins MW: Interpreting change on ImPACT following sport concussion. Clin Neuropsychol. 2003, 17: 460-467.CrossRefPubMed
Metadata
Title
Hyperbaric oxygen therapy (1.5 ATA) in treating sports related TBI/CTE: two case reports
Author
Kenneth P Stoller
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Medical Gas Research / Issue 1/2011
Electronic ISSN: 2045-9912
DOI
https://doi.org/10.1186/2045-9912-1-17

Other articles of this Issue 1/2011

Medical Gas Research 1/2011 Go to the issue

Research

Isoflurane does not cause neuroapoptosis but reduces astroglial processes in young adult mice

Commentary

Molecules, magic and forgetful fruit flies: the supernatural science of medical gas research

Research

Moderately delayed post-insult treatment with normobaric hyperoxia reduces excitotoxin-induced neuronal degeneration but increases ischemia-induced brain damage

Review

Oxygen/ozone as a medical gas mixture. A critical evaluation of the various methods clarifies positive and negative aspects

Commentary

The pacific chapter annual meeting of the undersea & hyperbaric medical society

Research

Open-label trial and randomized, double-blind, placebo-controlled, crossover trial of hydrogen-enriched water for mitochondrial and inflammatory myopathies
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits